Armstrong won't fight USADA charges, will lose Tour titles

Armstrong won't fight USADA charges, will lose Tour titles

Lance Armstrong's statement released Thursday night

USADA to strip Armstrong of Tour titles, ban for life

AUSTIN, Texas (AP) -- Lance Armstrong said Thursday night he is finished fighting a barrage of drug charges from the U.S. Anti-Doping Agency, putting his unprecedented string of seven Tour de France titles at risk along with his legacy as one of the greatest cyclists in history.

The decision sets up a likely lifetime ban from the sport and the possibility that Armstrong will be stripped of his signature achievement -- the extraordinary run of Tour titles he won from 1999-2005.

Armstrong, who retired last year, declined to enter arbitration -- his last option -- because he said he was weary of fighting accusations that have dogged him for years. He has consistently pointed to the hundreds of drug tests that he has passed as proof of his innocence.

"There comes a point in every man's life when he has to say, "Enough is enough." For me, that time is now," Armstrong said in a statement sent to The Associated Press. He called the USADA investigation an "unconstitutional witch hunt."

"I have been dealing with claims that I cheated and had an unfair advantage in winning my seven Tours since 1999," he said. "The toll this has taken on my family and my work for our foundation and on me leads me to where I am today - finished with this nonsense."

USADA will almost certainly treat Armstrong's decision as an admission of guilt, and hang the label of drug cheat on an athlete who was a hero to thousands for overcoming life-threatening testicular cancer and for his foundation's support for cancer research.

The agency can impose a lifetime ban and recommend Armstrong be stripped of his titles. That would put the question in the hands of the International Cycling Union, which has disputed USADA's authority to pursue the investigation and Tour de France officials, who have had a prickly relationship with Armstrong over the years.

Armstrong insisted his decision is not an admission of drug use, but a refusal to enter an arbitration process he believes is improper and unfair to athletes facing charges.

"USADA cannot assert control of a professional international sport and attempt to strip my seven Tour de France titles," he said. "I know who won those seven Tours, my teammates know who won those seven Tours, and everyone I competed against knows who won those seven Tours."

USADA maintains that Armstrong has used banned substances as far back as 1996, including the blood-booster EPO and steroids as well as blood transfusions -- all to boost his performance.

The 40-year-old Armstrong walked away from the sport in 2011 without being charged following a two-year federal criminal investigation into many of the same accusations he faces from USADA. The federal probe was closed in February, but USADA announced in June it had evidence Armstrong used banned substances and methods -- and encouraged their use by teammates. The agency also said it had blood tests from 2009 and 2010 that were "fully consistent" with blood doping.

Included in USADA's evidence were emails written by Armstrong's former U.S. Postal Service teammate Floyd Landis, who was stripped of his 2006 Tour de France title after a positive drug test. Landis' emails to a USA Cycling official detailed allegations of a complex doping program on the team.

USADA also said it had 10 former Armstrong teammates ready to testify against him. Other than suggesting they include Landis and Tyler Hamilton, both of whom have admitted to doping offenses, the agency has refused to say who they are or specifically what they would say.

"There is zero physical evidence to support (the) outlandish and heinous claims. The only physical evidence here is the hundreds of (doping) controls I have passed with flying colors," Armstrong said.

Armstrong sued USADA in Austin, where he lives, in an attempt to block the case and was supported by the UCI, the sport's governing body. A judge threw out the case on Monday, siding with USADA despite questioning the agency's pursuit of Armstrong in his retirement.

"USADA's conduct raises serious questions about whether its real interest in charging Armstrong is to combat doping, or if it is acting according to less noble motives," such as politics or publicity, U.S. District Judge Sam Sparks wrote.

Now the ultra-competitive Armstrong has done something virtually unthinkable for him: He has quit before a fight is over.

"Today I turn the page. I will no longer address this issue, regardless of the circumstances. I will commit myself to the work I began before ever winning a single Tour de France title: serving people and families affected by cancer, especially those in underserved communities," Armstrong said.

Armstrong could have pressed his innocence in USADA's arbitration process, but the cyclist has said he believes most people have already made up their minds about whether he's a fraud or a persecuted hero.

It's a stunning move for an athlete who built his reputation on not only beating cancer, but forcing himself through grueling offseason workouts no one else could match, then crushing his rivals in the Alps and the Pyrenees.

Although he had already been crowned a world champion and won individual stages at the Tour de France, Armstrong was still relatively unknown in the U.S. until he won the epic race for the first time in 1999. It was the ultimate comeback tale: When diagnosed with cancer, doctors had given him less than a 50 percent chance of survival before surgery and brutal cycles of chemotherapy saved his life.

Armstrong's riveting victories, his work for cancer awareness and his gossip-page romances with rocker Sheryl Crow, fashion designer Tory Burch and actress Kate Hudson made him a figure who transcended sports.

His dominance of the Tour de France elevated the sport's popularity in America to unprecedented levels. His story and success helped sell millions of the "Livestrong" plastic yellow wrist bracelets, and enabled him to enlist lawmakers and global policymakers to promote cancer awareness and research. His Lance Armstrong Foundation has raised nearly 500 million since its founding in 1997.

Created in 2000, USADA is recognized by Congress as the official anti-doping agency for Olympic sports in the United States. Its investigators joined U.S. agents during the federal probe, and USADA chief executive Travis Tygart had dismissed Armstrong's lawsuit as an attempt at "concealing the truth." He said the agency is motivated by one goal -- exposing cheaters in sport.

Others close to Armstrong were caught up in the charges: Johan Bruyneel, the coach of Armstrong's teams, and three members of the medical staff and a consultant were also charged. Bruyneel is taking his case to arbitration, while two medical team staffers and consulting doctor Michele Ferrari didn't formally contest the charges and were issued lifetime ban by USADA. Ferrari later said he was innocent.

In a sport rife with cheaters, Armstrong has been under constant suspicion since the 1990s from those who refused to believe he was a clean rider winning cycling's premier event against a field of doped-up competition.

He had tense public disputes with USADA, the World Anti-Doping Agency, some former teammates and assistants and even Greg LeMond, the first American to win the Tour de France.

Through it all, Armstrong vigorously denied any and all hints, rumors and direct accusations he was cheating. He had the blazing personality, celebrity and personal wealth needed to fight back with legal and public relations battles to clear his name -- and he did, time after time.

Armstrong won his first Tour at a time when doping scandals had rocked the race. He was leading the race when a trace amount of a banned anti-inflammatory corticosteroid was found in his urine; cycling officials said he was authorized to use a small amount of a cream to treat saddle sores.

After Armstrong's second victory in 2000, French judicial officials investigated his Postal Service team for drug use. That investigation ended with no charges, but the allegations kept coming.

Armstrong was criticized for his relationship with Ferrari, who was banned by Italian authorities over doping charges in 2002. Former personal and team assistants accused Armstrong of having steroids in an apartment in Spain and disposing of syringes that were used for injections.

In 2004, a Dallas-based promotions company initially refused to pay him a 5 million bonus for winning his sixth Tour de France because it wanted to investigate allegations raised by media in Europe. Testimony in that case included former teammate Frankie Andreu and his wife, Betsy, saying Armstrong told doctors during his 1996 cancer treatments that he had taken a cornucopia of steroids and performance-enhancing drugs.

Two books published in Europe, "L.A. Confidential" and "L.A. Official," also raised doping allegations and, in 2005, French magazine L'Equipe reported that retested urine samples from the 1999 Tour showed EPO use.

Armstrong fought every accusation with denials and, in some cases, lawsuits against the European media outlets that reported them.

But he showed signs that he was tiring of the never-ending questions. Armstrong retired (for the first time) in 2005 and almost immediately considered a comeback before deciding to stay on the sidelines, in part, because he didn't want to keep answering doping questions.

"I'm sick of this," Armstrong said in 2005. "Sitting here today, dealing with all this stuff again, knowing if I were to go back, there's no way I could get a fair shake -- on the roadside, in doping control, or the labs."

But three years later, Armstrong was 36 and itching to ride again. He came back to finish third in the 2009 Tour de France.

Armstrong raced in the Tour again in 2010, under the cloud of the federal criminal investigation. Early last year, he quit the sport for good, but made a brief return as a triathlete until the USADA investigation shut him down.

During his sworn testimony in the dispute over the 5 million bonus, Armstrong said he wouldn't take performance enhancing drugs because he had too much to lose.

"(The) faith of all the cancer survivors around the world. Everything I do off the bike would go away, too," Armstrong said then. "And don't think for a second I don't understand that. It's not about money for me. Everything. It's also about the faith that people have put in me over the years. So all of that would be erased."

Quick Links

Road ahead suggests a wild finish in Eastern Conference playoff race

USA Today Sports Images

Road ahead suggests a wild finish in Eastern Conference playoff race

The Eastern Conference standings are so closely bunched as of today that the third-place Cleveland Cavaliers are only 1 1/2 games ahead of the sixth-place Philadelphia 76ers. With roughly a dozen games remaining for each NBA team, much can and likely will change over the next several weeks.

That is common for this time of the year, but a closer look suggests we could be in for some chaos in the final stretch. There are lopsided remaining schedules and impending personnel changes which could all contribute to one of the wildest regular season finishes in recent memory.

The Wizards are smack dab in the middle of the East playoff race and have their own circumstances to navigate. Let's take a team-by-team look at the middle of the Eastern Conference playoff picture, knowing the top two seeds are all but locked up by the Toronto Raptors and Boston Celtics...


3. Cleveland Cavaliers (41-29, 12 games left)

Monday was a crazy day for the Cavaliers. First, they announced their head coach Tyronn Lue is taking a leave of absence to deal with an undiagnosed health issue. He will be replaced by associate head coach Larry Drew in the interim as he hopes to heal up before the playoffs.

Then, news broke they were getting Kevin Love back from a broken wrist after missing 21 games. Love returned to put up 18 points, seven rebounds, four assists and two blocks in a big win over the Milwaukee Bucks. 

The Cavaliers will be without their coach for an undefined period of time, but now have their second-best player back on the court. That makes their final part of the season extra fascinating.

The Cavs are the team to watch of this group. Even though this season has been filled with turmoil, they still have LeBron James. He and Love have helped form the core of the last three Eastern Conference champion teams. If they pick things up, it's not crazy to consider them among the favorites to get out of the East again.


4. Indiana Pacers (41-30, 11 games left)

The Pacers are mostly healthy as they only feature a slew of minor injuries to big men Myles Turner and Domantas Sabonis. But Indiana's remaining schedule is unusually tough and it could make the difference in where they end up.

With only 11 games remaining, the Pacers still have to play the first-place Toronto Raptors once and the Golden State Warriors twice. Six of their last eight games will be on the road. They also see the Heat, Pelicans, Nuggets and Clippers.

The Clippers are currently ninth in the West and battling to make the playoffs. The Pacers will play them twice.

Keep in mind the Wizards own the season series over Indiana and will have a playoff seeding tiebreaker if they end up with the same record. Also worth noting is the Pacers have been much better at home (24-13) than on the road (17-17) this season.


5. Washington Wizards (40-30, 12 games left)

Though the Wizards' schedule is finally letting up soon from the 13 straight playoff teams stretch they have had to endure dating back to February, they too have a tough road ahead. The Wizards still have to play the Spurs (twice), Rockets, Cavaliers, Celtics and Nuggets. Four of their last six games are on the road and they have three back-to-back sets in their final seven games.

That's brutal. They may not have to see the defending champions twice like Indiana does, but the Wizards don't exactly have it easy.

The Wizards will, however, get John Wall back at some point. The five-time All-Star is slowly but surely working his way back and could participate in a full practice by the end of the week. Ideally they will get some games under his belt before the playoffs, but any time an All-NBA player is coming back to your team it's a good thing.

The problem is that there is little room for error in the standings and head coach Scott Brooks will have to reinsert Wall into the lineup during a tough schedule and while Wall is on a minutes restriction. It will be a tricky task to balance his lineups. 


6. Philadelphia 76ers (39-30, 13 games left)

The Sixers may have the most ideal road ahead of these four teams, at least in terms of their schedule. They still have the Timberwolves, Nuggets, Cavs and Bucks. But none of those teams are the juggernauts that Golden State, Houston and Toronto are. And of their final 13 games, the Sixers will play nine against teams outside of the playoff picture.

Philly also does not have to reincorporate a major piece into their rotation, like the Cavs do with Love and the Wizards with Wall. Their biggest injury is to Markelle Fultz, the 2017 No. 1 overall pick. If he does return this season, it will likely be in a minimal role, at least to start.

What could work against the Sixers is their inexperience and recent struggles against good teams. The Sixers are relying on very young players who have never been here before to carry the way. And since Valentine's Day, Philly has just one win against a team above the .500 mark, when they beat the Cavs on March 1. During those 14 games since Feb. 14, they have beaten up on the bad teams but lost to the Wizards, Bucks, Pacers and Heat (twice), basically all the teams surrounding them in the standings. 

Philly also lost their season series against the Cavs and Pacers, tied with the Wizards and are down 2-1 against the Bucks with one game to go. They may go to the finish line without a playoff tiebreaker against all the teams they would want one against.

NBC Sports Washington is on Apple News. Favorite us!

Quick Links

Ryan Grant reportedly signing with Colts after failed physical with Ravens

USA Today Sports Images

Ryan Grant reportedly signing with Colts after failed physical with Ravens

It looks like Ryant Grant has found his new home, again.

After a failed physical with the Ravens, James Jones of NFL Network reports Grant plans to sign with the Colts.


Grant originally agreed to a four-year, $29 million deal with the Ravens, before the team pulled the offer citing an ankle injury that dated to the Redskins' final regular-season game, according to reports.

Baltimore eventually signed Michael Crabtree to a three-year deal, while Grant had visits with the Colts and Raiders.

His agent, Rocky Arceneaux, says Grant has been working out, running routes, and his ankle had been cleared by Dr. Robert Anderson in a second opinion.

In 2017 with the Redskins, he appeared in all 16 games, with 45 receptions for 573 yards and four touchdowns.